Published On: Wed, Oct 19th, 2016

Imprivata, Inc. (NYSE:IMPR) Updated Broker Ratings


A number of investment brokers have recently updated their price targets on shares of Imprivata, Inc. (NYSE:IMPR).

Most recent broker ratings

08/02/2016 – Imprivata, Inc. was downgraded to “market perform” by analysts at Wells Fargo.

07/14/2016 – Imprivata, Inc. was downgraded to “market perform” by analysts at Leerink Swann.

07/13/2016 – Imprivata, Inc. was downgraded to “hold” by analysts at Stifel Nicolaus.

07/13/2016 – Imprivata, Inc. was downgraded to “neutral” by analysts at Piper Jaffray.

02/17/2016 – Imprivata, Inc. had its “neutral” rating reiterated by analysts at JP Morgan. They now have a USD 17 price target on the stock.

02/17/2016 – Imprivata, Inc. had its “overweight” rating reiterated by analysts at Barclays. They now have a USD 14 price target on the stock.

02/17/2016 – Imprivata, Inc. had its “outperform” rating reiterated by analysts at Oppenheimer. They now have a USD 16 price target on the stock.

11/03/2015 – Imprivata, Inc. had its “buy” rating reiterated by analysts at Topeka Capital Markets. They now have a USD 17 price target on the stock.

10/15/2015 – Imprivata, Inc. was downgraded to “market perform” by analysts at William Blair.

06/18/2015 – Imprivata, Inc. had its “outperform” rating reiterated by analysts at Stephens. They now have a USD 20 price target on the stock.

05/13/2015 – Imprivata, Inc. was downgraded to “sell” by analysts at Zacks.

The share price of Imprivata, Inc. (NYSE:IMPR) was up +0.00% during the last day of trading, with a day high of 0.00. 0 shares were traded during the last session.

The stock’s 50 day moving average is 19.25 and its 200 day moving average is 16.17.Imprivata, Inc. has a 52-week low of 9.00 and a 52-week high of 19.28.

Imprivata, Inc. (Imprivata) is a United States-based healthcare information technology security company. The Company enables healthcare organizations to access, communicate and transact patient information securely. The Company offers Imprivata OneSign, Imprivata Cortext, Imprivata Confirm ID and Imprivata PatientSecure. Imprivata OneSign provides single sign-on, authentication management and virtual desktop roaming, enabling No Click Access to clinical applications and patient information, anytime, anywhere and from any device. Imprivata Cortext enables clinicians to collaborate across care teams and organizations. Imprivata Confirm ID is an identity and two-factor authentication platform for remote access, electronic prescriptions for controlled substances (EPCS), medical device access and other clinical authentication workflows. Imprivata PatientSecure is a patient identification solution that uses palm vein recognition biometrics to identify patients at any point of entry to care.